NCT04935684

Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation

RecruitingPHASE2INTERVENTIONAL

Trial Details

Start: 2022-12-20Est. Completion: 2030-05

Enrollment target: 150 participants

Locations

Service d'Hématologie Clinique et Thérapie Cellulaire CHU Amiens Picardie - Site Sud, Amiens, France
Service Maladies du sang CHU Angers, Angers, France
Hématologie clinique CHU Besançon, Besançon, France
Plateforme d'Investigation Clinique / Centre d'Investigation Clinique - Inserm 1405, CHU Gabriel Montpied Clermont-Ferrand, Clermont-Ferrand, France
Service de thérapie Cellulaire et d'Hématologie Clinique Adulte CHU Estaing - Clermont-Ferrand, Clermont-Ferrand, France
Service hématologie CHU Grenoble, Grenoble, France
Service des Maladies du sang Hôpital HURIEZ, CHRU de Lille, Lille, France
Service de thérapie cellulaire et l'hématologie clinique adulte CHU Limoges, Limoges, France
Service d'Hématologie Centre Hospitalier Lyon Sud, Lyon, France
Service d'Hématologie et de Médecine interne Hôpital Brabois CHRU Nancy, Nancy, France
Service d'Hématologie Clinique CHU Nantes, Nantes, France
Service d'hématologie clinique, département de greffe de moelle CHU Nice, Nice, France
Service d'Hématologie Adultes Hôpital Necker, Paris, France
Service d'Hématologie clinique Hôpital Pitié-Salpêtrière, Paris, France

Hypoplastic Acute Myeloid LeukemiaSecondary AML (Adult)

The purpose of this study is to explore the efficacy and safety of venetoclax combined with azacitidine（VA) induction fo…

Suzhou, ChinaEst. completion May 31, 2029

B-AllAcute Lymphoblastic Leukemia

Background: Chimeric antigen receptor T-cell (CART) therapy is a form of immunotherapy which can be used to treat peopl…

Los Angeles, United StatesEst. completion Dec 31, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.